Drugs & TargetsFree Halaven approved for unresectable or metastatic liposarcoma January 29, 2016Vol.42 No.04
Drugs & TargetsFree FDA Expands Opdivo-Yervoy Label with Accelerated Approval January 29, 2016Vol.42 No.04
Drugs & Targets Venetoclax Receives FDA Breakthrough Therapy Designation January 22, 2016Vol.42 No.03
Drugs & Targets Blincyto Receives Conditional Approval from Health Canada January 16, 2016Vol.42 No.02
Drugs & Targets MD Anderson and DelMar Pharmaceuticals form collaboration January 16, 2016Vol.42 No.02
Drugs & Targets Eisai submits MAA to European Medicines Agency for lenvatinib January 16, 2016Vol.42 No.02
Drugs & Targets Sorrento Therapeutics and Karolinska Institutet form collaboration January 16, 2016Vol.42 No.02
